MIRA
INFORM REPORT
|
Report Date : |
29.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
hec
pharm co., ltd. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
01.12.2004 |
|
|
|
|
Com. Reg. No.: |
420500400000612 |
|
|
|
|
Legal Form : |
Shares Limited Company |
|
|
|
|
Line of Business : |
Manufacturing,
and selling active pharmaceutical ingredients and pharmaceutical
intermediates. |
|
|
|
|
No. of Employees : |
800 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 2,000,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
hec pharm co., ltd.
no. 62
binjiang road, yidu city
yichang, hubei
PROVINCE 443300 PR CHINA
TEL: 86
(0) 717-4903275/4904118
FAX: 86
(0) 717-4903272
EXECUTIVE SUMMARY
Date of Registration : january 12, 2004
REGISTRATION NO. : 420500400000612
LEGAL FORM : SHARES LIMITED COMPANY
REGISTERED CAPITAL :
CNY 720,000,000
staff : 800
BUSINESS CATEGORY :
MANUFACTURING & TRADING
Revenue : n/a
EQUITIES : n/a
PAYMENT : AVERAGE
Recommended Credit Limit: UP TO USD
2,000,000
MARKET CONDITION : COMPETITIVE
FINANCIAL CONDITION : N/A
OPERATIONAL TREND :
fairly steady
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.30 = USD 1
Adopted abbreviations (as
follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
LEGAL STATUS & HISTORY
SC was established as a shares
limited company of PRC with State Administration of Industry &
Commerce (SAIC) under registration No.: 420500400000612
on January 12, 2004.
SC’s Organization Code Certificate No.:
75701795-5
SC’s registered capital: CNY 720,000,000
SC’s paid-in capital: CNY 720,000,000
Registration Change Record:
No significant changes of SC have
been noted in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief
executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Guangdong Dongyangguang
Aluminum Co., Ltd. |
75 |
|
Shenzhen Dongyangguang Pharmaceutical
Investment Co., Ltd. |
|
|
Jianyin International Medical
Industry Equity Investment Co., Ltd. |
|
|
Dongguan Technology &
Venture Investment Partnership Enterprise (Limited Partnership) |
|
|
Zhongyin International
Investment Co., Ltd. |
|
|
Dongguan Dongyangguang
Industry Development Co., Ltd. |
|
|
North & South Brother
Pharmacy Investment Company Limited |
25 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative,
Chairman, and General Manager |
Zhu Yingwei |
RECENT DEVELOPMENT
No recent development was found during our checks at present.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
Guangdong Dongyangguang Aluminum
Co., Ltd.
Shenzhen Dongyangguang
Pharmaceutical Investment Co., Ltd.
Jianyin International Medical
Industry Equity Investment Co., Ltd.
Dongguan Technology &
Venture Investment Partnership Enterprise
(Limited Partnership)
Zhongyin International
Investment Co., Ltd.
Dongguan Dongyangguang Industry
Development Co., Ltd.
-------------------------------------------------------------------------------------
Domestic Shareholders, 75
North & South Brother
Pharmacy Investment Company Limited (Hong Kong)
--------------------------------------------------------------------------------------
Overseas Shareholder, 25
Guangdong Dongyangguang Aluminum Co.,
Ltd.
======================================
Date of Registration: October 24, 1996
Registration No.: 440200000013599
Legal Form: Shares Limited Company
Registered Capital: CNY 827,466,788
MANAGEMENT
Zhu
Yingwei, Legal
Representative, Chairman and General Manager
-----------------------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Qualification:
University
Ø
Working
experience (s):
At present, working in SC as legal representative, chairman
and general manager
BUSINESS OPERATION
SC’s
registered business scope includes researching, manufacturing, and selling
active pharmaceutical ingredients and pharmaceutical intermediates.
SC is mainly
engaged in manufacturing and selling active
pharmaceutical ingredients and pharmaceutical intermediates.
SC’s products mainly include:
erythromycin, clarithromycin, etc.
SC sources its materials 100%
from domestic market. SC sells 60% of its products in domestic market, and 40%
to overseas market.
The buying terms of SC include Check, T/T and Credit of
30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60
days.
Staff & Office:
--------------------------
SC is
known to have approx. 800 staff at present.
SC rents an area
as its operating office and factory, but the detailed information is unknown.
RELATED COMPANY
SC
is not known to have any subsidiary at present.
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
The bank
information of SC is not filed in local SAIC.
FINANCIALS
The financials of SC is not available in
local SAIC, and SC also refused to release the details.
CONCLUSIONS
SC is considered medium-sized in its line with
8 years business history. A credit line up to USD 2,000,000 would appear
to be within SC’s capacities.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.91 |
|
|
1 |
Rs.81.21 |
|
Euro |
1 |
Rs.67.85 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.